Trial Profile
Clinical Trials Insight: 700014603
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Feb 2009
Price :
$35
*
At a glance
- Drugs Davunetide (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Allon Therapeutics
- 07 Mar 2007 Status changed from in progress to completed.
- 31 Aug 2006 New trial record.